0.0005
0.0000
(0.00%)
At close: January 31 at 8:20:38 AM GMT+1
Breakdown
TTM
3/31/2022
3/31/2021
3/31/2020
Operating Cash Flow
-433.0970
-1,345.6670
-845.1660
-717.8120
Investing Cash Flow
--
--
43.7170
-43.2030
Financing Cash Flow
228.2610
139.9820
1,927.4570
1,300.5260
End Cash Position
259.2590
464.0950
1,669.7800
543.7720
Capital Expenditure
--
--
-0.6050
-43.2030
Issuance of Capital Stock
228.2610
139.9820
2,005.8990
1,337.5000
Issuance of Debt
0.5050
--
--
0.5050
Repayment of Debt
--
--
-75.3880
-3.1620
Free Cash Flow
-433.0970
-1,345.6670
-845.7710
-761.0150
3/31/2020 - 1/25/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABTEC.OL Aqua Bio Technology ASA
3.2400
+3.18%
ALNEV.PA Neovacs S.A.
0.2600
-18.75%
GRTSQ Gritstone bio, Inc.
0.0010
0.00%
RENB Renovaro Inc.
0.7500
-1.99%
OMGA Omega Therapeutics, Inc.
0.4900
+5.24%
IVVD Invivyd, Inc.
0.3577
-8.28%
TECX Tectonic Therapeutic, Inc.
54.14
-1.28%
VERU Veru Inc.
0.5557
-4.27%
ATHE Alterity Therapeutics Limited
4.8000
+5.03%
HEPA Hepion Pharmaceuticals, Inc.
0.1795
-3.80%